Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors-Reference-Cited by-同舟云学术

Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors

Published:2012-01-19 Issue:6 Volume:109 Page:2168-2173
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Bard-Chapeau E. A.,Jeyakani J.,Kok C. H.,Muller J.,Chua B. Q.,Gunaratne J.,Batagov A.,Jenjaroenpun P.,Kuznetsov V. A.,Wei C.-L.,D'Andrea R. J.,Bourque G.,Jenkins N. A.,Copeland N. G.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference40 articles.

1. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated

2. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies

3. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

4. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-Cas9-mediated deletion enhancer of MECOM play a tumor suppressor role in ovarian cancer;Functional & Integrative Genomics;2024-07-12

2. The ETV6-MECOM fusion protein promotes EMT-related properties by repressing the transactivation activity of E-cadherin promoter in K562 leukemia cells;Biochemistry and Biophysics Reports;2024-07

3. Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML;Nature Communications;2024-06-04

4. The PR factor Hamlet controls heterotypic epithelial tissue assembly inDrosophilareproduction system;2024-04-10

5. EVI1-mediated Programming of Normal and Malignant Hematopoiesis;HemaSphere;2023-10